Insight Molecular Diagnostics Inc. (IMDX) News
Follow Insight Molecular Diagnostics Inc. (IMDX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Insight Molecular Diagnostics amends Chronix merger terms
The company said Amendment No. 2 to its merger agreement with Chronix equityholder representative sets a 10% royalty on CNI Monitor sales until the earlier of a sale of CNI Monitor or expiration of related IP, plus a 10%
MNA | Sep 21, 2026, 08:15 PM UTC
L
IMDX - iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
IMDX - iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
EQUITY | Sep 02, 2026, 12:00 PM UTC
L
Insight Molecular Diagnostics To Host Virtual KOL Event On August 17 To Discuss GraftAssure Platform Leveraging Digital PCR Technology For R
Insight Molecular Diagnostics Inc., (NASDAQ: IMDX ), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola Universi
REGULATION | Aug 11, 2026, 08:17 PM UTC
L
IMDX Hosts Virtual Event on Organ Rejection Testing
IMDX is hosting a virtual KOL event on August 17, 2026, on in-house heart transplanted organ rejection testing
EQUITY | Aug 11, 2026, 08:09 PM UTC
L
IMDX - iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference - Click For
IMDX - iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
EARNINGS | Aug 04, 2026, 11:02 AM UTC